Atara Biotherapeutics, Inc. SEC filings ATRA

Atara Biotherapeutics, Inc. has 1,002 filings in SEC EDGAR's recent list, going back to Jul 9, 2015. Its latest annual report, Form 10-K, was filed on Mar 16, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 12, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Aug 12, 2026 (results of operations). The company's fiscal year ends on December 31.

Atara Biotherapeutics, Inc. SEC filings
Form Description Filed Period
10-Q Quarterly report Aug 12, 2026 Jun 30, 2026
8-K Current report
Results of operations
Aug 12, 2026 Aug 12, 2026
8-K Current report
Officer or director change
Jun 26, 2026 Jun 22, 2026
S-8 Employee stock plan registration Jun 12, 2026 —
8-K Current report
Officer or director change, Shareholder vote results
Jun 12, 2026 Jun 9, 2026
424B5 Prospectus supplement May 12, 2026 —
10-Q Quarterly report May 12, 2026 Mar 31, 2026
8-K Current report May 12, 2026 May 12, 2026
8-K Current report
Other events
May 7, 2026 May 7, 2026
8-K Current report
Listing notice
May 1, 2026 Apr 30, 2026
DEF 14A Proxy statement Apr 24, 2026 Apr 24, 2026
DEFA14A Additional proxy material Apr 24, 2026 —
EFFECT Filing Mar 25, 2026 —
424B3 Prospectus Mar 25, 2026 —
CORRESP Letter to the SEC Mar 23, 2026 —
UPLOAD Letter from the SEC Mar 20, 2026 —
S-3 Shelf registration Mar 17, 2026 —
424B5 Prospectus supplement Mar 16, 2026 —
10-K Annual report Mar 16, 2026 Dec 31, 2025
8-K Current report
Results of operations
Mar 16, 2026 Mar 16, 2026
8-K Current report
Other events
Mar 12, 2026 Mar 12, 2026
8-K Current report
Other events
Mar 3, 2026 Mar 3, 2026
8-K Current report
Material agreement, Unregistered share sale, Other events
Feb 23, 2026 Feb 20, 2026
8-K Current report
Results of operations, Other events
Jan 12, 2026 Jan 12, 2026
8-K Current report
Material agreement
Jan 2, 2026 Dec 30, 2025
10-Q Quarterly report Nov 12, 2025 Sep 30, 2025
8-K Current report
Results of operations
Nov 12, 2025 Nov 12, 2025
8-K Current report
Exit or restructuring costs
Oct 7, 2025 Oct 6, 2025
8-K Current report
Officer or director change
Sep 4, 2025 Sep 2, 2025
10-Q Quarterly report Aug 11, 2025 Jun 30, 2025
8-K Current report
Results of operations
Aug 11, 2025 Aug 11, 2025
8-K Current report
Results of operations, Other events
Jul 14, 2025 Jul 14, 2025
8-K Current report
Shareholder vote results
Jun 11, 2025 Jun 10, 2025
8-K Current report
Other events
May 16, 2025 May 14, 2025
424B5 Prospectus supplement May 15, 2025 —
10-Q Quarterly report May 15, 2025 Mar 31, 2025
8-K Current report
Results of operations, Officer or director change
May 15, 2025 May 14, 2025
8-K Current report
Exit or restructuring costs
May 12, 2025 May 12, 2025
8-K Current report
Other events
May 6, 2025 May 5, 2025
DEFA14A Additional proxy material Apr 28, 2025 —
DEF 14A Proxy statement Apr 28, 2025 Jun 10, 2025
8-K Current report
Material agreement
Apr 4, 2025 Mar 31, 2025
8-K Current report
Officer or director change
Mar 31, 2025 Mar 25, 2025
10-K Annual report Mar 7, 2025 Dec 31, 2024
8-K Current report
Results of operations
Mar 7, 2025 Mar 7, 2025
8-K Current report
Exit or restructuring costs
Mar 3, 2025 Mar 3, 2025
8-K Current report
Exit or restructuring costs
Jan 27, 2025 Jan 27, 2025
8-K Current report
Other events
Jan 21, 2025 Jan 21, 2025
S-8 Employee stock plan registration Jan 17, 2025 —
8-K Current report
Results of operations, Other events
Jan 16, 2025 Jan 16, 2025
8-K Current report
Bylaw or fiscal year change
Dec 23, 2024 Dec 20, 2024
10-Q Quarterly report Nov 12, 2024 Sep 30, 2024
8-K Current report
Results of operations, Officer or director change
Nov 12, 2024 Nov 8, 2024
8-K Current report
Officer or director change
Oct 15, 2024 Oct 14, 2024
424B5 Prospectus supplement Sep 4, 2024 —
8-K Current report
Officer or director change, Other events
Sep 3, 2024 Sep 3, 2024
10-Q Quarterly report Aug 12, 2024 Jun 30, 2024
8-K Current report
Results of operations, Officer or director change
Aug 12, 2024 Aug 10, 2024
8-K Current report
Other events
Jul 17, 2024 Jul 17, 2024
8-K Current report
Change to shareholder rights, Bylaw or fiscal year change
Jun 20, 2024 Jun 20, 2024
8-K Current report
Other events
Jun 17, 2024 Jun 17, 2024
S-8 Employee stock plan registration Jun 11, 2024 —
S-8 Employee stock plan registration Jun 11, 2024 —
8-K Current report
Shareholder vote results
Jun 11, 2024 Jun 10, 2024
DEFR14A Filing May 10, 2024 —
10-Q Quarterly report May 9, 2024 Mar 31, 2024
8-K Current report
Results of operations
May 9, 2024 May 9, 2024
DEFA14A Additional proxy material Apr 26, 2024 —
DEF 14A Proxy statement Apr 26, 2024 Jun 10, 2024
PRE 14A Preliminary proxy statement Apr 12, 2024 Jun 10, 2024
8-K Current report
Officer or director change
Mar 29, 2024 Mar 26, 2024
10-K Annual report Mar 28, 2024 Dec 31, 2023
8-K Current report
Results of operations
Mar 28, 2024 Mar 28, 2024
8-K Current report
Officer or director change
Feb 23, 2024 Feb 22, 2024
424B5 Prospectus supplement Jan 9, 2024 —
8-K Current report
Material agreement, Listing notice
Jan 9, 2024 Jan 8, 2024
8-K Current report
Exit or restructuring costs, Officer or director change, Regulation FD disclosure, Other events
Jan 8, 2024 Jan 8, 2024
S-8 Employee stock plan registration Jan 3, 2024 —
8-K Current report
Other events
Dec 20, 2023 Dec 20, 2023
424B3 Prospectus Nov 17, 2023 —
EFFECT Filing Nov 13, 2023 —
8-K Current report
Other events
Nov 9, 2023 Nov 8, 2023
CORRESP Letter to the SEC Nov 8, 2023 —
UPLOAD Letter from the SEC Nov 6, 2023 —
S-3 Shelf registration Nov 1, 2023 —
8-K Current report
Other events
Nov 1, 2023 Nov 1, 2023
10-Q Quarterly report Nov 1, 2023 Sep 30, 2023
8-K Current report
Material agreement, Results of operations, Exit or restructuring costs
Nov 1, 2023 Oct 31, 2023
8-K Current report
Other events
Sep 20, 2023 Sep 19, 2023
10-Q Quarterly report Aug 8, 2023 Jun 30, 2023
8-K Current report
Results of operations
Aug 8, 2023 Aug 8, 2023
8-K Current report
Officer or director change
Jun 9, 2023 Jun 9, 2023
8-K Current report
Officer or director change, Shareholder vote results
Jun 5, 2023 May 31, 2023
8-K Current report
Officer or director change
May 12, 2023 May 12, 2023
10-Q Quarterly report May 8, 2023 Mar 31, 2023
8-K Current report
Results of operations, Officer or director change
May 8, 2023 May 5, 2023
UPLOAD Letter from the SEC May 2, 2023 —
CORRESP Letter to the SEC Apr 21, 2023 —
DEFA14A Additional proxy material Apr 7, 2023 —
DEF 14A Proxy statement Apr 7, 2023 —
8-K Current report
Officer or director change
Mar 31, 2023 Mar 31, 2023
UPLOAD Letter from the SEC Mar 27, 2023 —
PRE 14A Preliminary proxy statement Mar 24, 2023 —
8-K Current report
Regulation FD disclosure
Mar 10, 2023 Mar 10, 2023
EFFECT Filing Feb 13, 2023 —
POS AM Filing Feb 9, 2023 —
S-8 Employee stock plan registration Feb 9, 2023 —
10-K Annual report Feb 8, 2023 Dec 31, 2022
POSASR Filing Feb 8, 2023 —
8-K Current report
Results of operations, Officer or director change
Feb 8, 2023 Feb 3, 2023
8-K Current report
New debt
Jan 6, 2023 Dec 30, 2022
8-K Current report
Material agreement
Dec 20, 2022 Dec 20, 2022
8-K Current report
Officer or director change, Other events
Dec 19, 2022 Dec 16, 2022
10-Q Quarterly report Nov 8, 2022 Sep 30, 2022
8-K Current report
Results of operations
Nov 8, 2022 Nov 8, 2022
8-K Current report
Material agreement
Sep 28, 2022 Sep 28, 2022
8-K Current report
Bylaw or fiscal year change
Sep 27, 2022 Sep 26, 2022
10-Q Quarterly report Aug 8, 2022 Jun 30, 2022
8-K Current report
Material agreement, Results of operations, Exit or restructuring costs, Officer or director change
Aug 8, 2022 Aug 2, 2022
S-8 Employee stock plan registration Jul 22, 2022 —
8-K Current report
Shareholder vote results
Jun 24, 2022 Jun 23, 2022
8-K Current report
Agreement ended
May 19, 2022 May 13, 2022
10-Q Quarterly report May 5, 2022 Mar 31, 2022
8-K Current report
Results of operations
May 5, 2022 May 5, 2022
DEFA14A Additional proxy material Apr 27, 2022 —
DEF 14A Proxy statement Apr 27, 2022 Jun 23, 2022
8-K Current report
Acquisition or sale of assets
Apr 4, 2022 Apr 4, 2022
S-8 Employee stock plan registration Feb 28, 2022 —
10-K Annual report Feb 28, 2022 Dec 31, 2021
8-K Current report
Results of operations
Feb 28, 2022 Feb 28, 2022
8-K Current report
Other events
Feb 18, 2022 Feb 18, 2022
8-K Current report
Material agreement, Results of operations, Officer or director change
Jan 26, 2022 Jan 26, 2022
8-K Current report
Regulation FD disclosure
Jan 10, 2022 Jan 10, 2022
8-K Current report
Other events
Nov 26, 2021 Nov 26, 2021
424B5 Prospectus supplement Nov 26, 2021 —
10-Q Quarterly report Nov 4, 2021 Sep 30, 2021
8-K Current report
Results of operations
Nov 4, 2021 Nov 4, 2021
8-K Current report
Material agreement
Oct 4, 2021 Oct 2, 2021
S-8 Employee stock plan registration Sep 29, 2021 —
8-K Current report
Officer or director change
Aug 10, 2021 Aug 9, 2021
10-Q Quarterly report Aug 9, 2021 Jun 30, 2021
8-K Current report
Results of operations
Aug 9, 2021 Aug 9, 2021
8-K Current report
Shareholder vote results
Jun 9, 2021 Jun 8, 2021
DEFA14A Additional proxy material May 28, 2021 —
10-Q Quarterly report May 4, 2021 Mar 31, 2021
8-K Current report
Results of operations
May 4, 2021 May 4, 2021
DEFA14A Additional proxy material Apr 22, 2021 —
DEF 14A Proxy statement Apr 22, 2021 Jun 8, 2021
S-8 Employee stock plan registration Mar 1, 2021 —
S-3ASR Automatic shelf registration Mar 1, 2021 —
10-K Annual report Mar 1, 2021 Dec 31, 2020
8-K Current report
Results of operations
Mar 1, 2021 Mar 1, 2021
8-K Current report
Regulation FD disclosure
Jan 11, 2021 Jan 11, 2021
8-K Current report
Other events
Jan 4, 2021 Jan 4, 2021
8-K Current report
Other events
Dec 9, 2020 Dec 8, 2020
424B5 Prospectus supplement Dec 9, 2020 —
424B5 Prospectus supplement Dec 7, 2020 —
8-K Current report
Material agreement
Dec 7, 2020 Dec 4, 2020
S-8 Employee stock plan registration Nov 9, 2020 —
10-Q Quarterly report Nov 9, 2020 Sep 30, 2020
8-K Current report
Results of operations
Nov 9, 2020 Nov 9, 2020
10-Q Quarterly report Aug 5, 2020 Jun 30, 2020
8-K Current report
Results of operations
Aug 5, 2020 Aug 5, 2020
8-K Current report
Shareholder vote results
Jun 19, 2020 Jun 16, 2020
DEFA14A Additional proxy material Jun 5, 2020 —
8-K Current report
Other events
May 28, 2020 May 26, 2020
424B5 Prospectus supplement May 27, 2020 —
424B5 Prospectus supplement May 26, 2020 —
8-K Current report
Officer or director change
May 12, 2020 May 8, 2020
10-Q Quarterly report May 6, 2020 Mar 31, 2020
8-K Current report
Results of operations
May 6, 2020 May 6, 2020
8-K Current report
Officer or director change
Apr 30, 2020 Apr 29, 2020
DEFA14A Additional proxy material Apr 22, 2020 —
DEF 14A Proxy statement Apr 22, 2020 Jun 16, 2020
S-8 Employee stock plan registration Feb 27, 2020 —
424B5 Prospectus supplement Feb 27, 2020 —
10-K Annual report Feb 27, 2020 Dec 31, 2019
8-K Current report
Results of operations
Feb 27, 2020 Feb 27, 2020
10-Q Quarterly report Nov 7, 2019 Sep 30, 2019
8-K Current report
Results of operations
Nov 7, 2019 Nov 7, 2019
8-K Current report
Officer or director change
Oct 25, 2019 Oct 21, 2019
10-Q Quarterly report Aug 8, 2019 Jun 30, 2019
8-K Current report
Results of operations
Aug 8, 2019 Aug 8, 2019
8-K Current report
Results of operations, Other events
Jul 22, 2019 Jul 18, 2019
424B5 Prospectus supplement Jul 19, 2019 —
424B5 Prospectus supplement Jul 18, 2019 —
8-K Current report
Shareholder vote results
Jun 28, 2019 Jun 27, 2019
8-K Current report
Other events
Jun 5, 2019 Jun 5, 2019
8-K Current report
Officer or director change
May 28, 2019 May 23, 2019
10-Q Quarterly report May 9, 2019 Mar 31, 2019
8-K Current report
Results of operations
May 9, 2019 May 9, 2019
DEFA14A Additional proxy material Apr 30, 2019 —
DEF 14A Proxy statement Apr 30, 2019 Jun 27, 2019
8-K Current report
Officer or director change
Apr 3, 2019 Mar 29, 2019
CT ORDER Filing Mar 11, 2019 —
S-8 Employee stock plan registration Feb 26, 2019 —
424B5 Prospectus supplement Feb 26, 2019 —
10-K Annual report Feb 26, 2019 Dec 31, 2018
8-K Current report
Results of operations
Feb 26, 2019 Feb 26, 2019
8-K Current report
Officer or director change
Jan 3, 2019 Jan 2, 2019

Showing 200 filings, the most recent 200. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Biological Products, (No Diagnostic Substances) (SIC 2836)
Listed as
ATRA (Nasdaq)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Thousand Oaks, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1604464

Other Biological Products, (No Diagnostic Substances) companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.